Vivos Therapeutics (VVOS) Other Non Operating Income (2021 - 2026)
Vivos Therapeutics' (VVOS) quarterly Other Non Operating Income came in at -$1.2 million in Q1 2026, down 29075.0% year-on-year from N/an in Q1 2025, and down 84.94% on a QoQ basis from -$631000.0 in Q4 2025.
Vivos Therapeutics (VVOS) Other Non Operating Income (2021 - 2026) Analysis & Trends
Vivos Therapeutics (VVOS) has 6 years of Other Non Operating Income data on file, last reported at -$1.2 million in Q1 2026.
- On a quarterly basis, Other Non Operating Income fell 29075.0% year-over-year to -$1.2 million in Q1 2026; TTM through Mar 2026 was -$2.6 million, a 2257.14% decrease from a year earlier, with the FY2025 full-year figure at -$1.5 million, down 1246.36% from the prior year.
- Other Non Operating Income for Q1 2026 stood at -$1.2 million, down from -$631000.0 in the prior quarter.
- Over the last five years, Other Non Operating Income for VVOS reached as high as $51000.0 in Q1 2023 and fell as low as -$1.2 million in Q1 2026.
- Historically, Other Non Operating Income has averaged -$184882.4 across 5 years, with a median of -$38000.0 in 2022.
- Across the five-year window, Other Non Operating Income soared 234.21% in 2023 and sank 29075.0% in 2026, its largest moves.
- Year by year, Other Non Operating Income stood at -$38000.0 in 2022, then surged by 63.16% to -$14000.0 in 2023, then sank by 385.71% to -$68000.0 in 2024, then plunged by 827.94% to -$631000.0 in 2025, then tumbled by 84.94% to -$1.2 million in 2026.
- Per Business Quant data, the three most recent Other Non Operating Income figures were -$1.2 million in Q1 2026, -$631000.0 in Q4 2025, and -$679000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Vivos Therapeutics | 3.62 Mn | 1.38 Mn | 3.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.17 Mn |
| Dec 31, 2025 | -631,000.00 |
| Sep 30, 2025 | -679,000.00 |
| Jun 30, 2025 | -163,000.00 |
| Mar 31, 2025 | -4,000.00 |
| Dec 31, 2024 | -68,000.00 |
| Sep 30, 2024 | -18,000.00 |
| Jun 30, 2024 | -22,000.00 |
| Mar 31, 2024 | -1,000.00 |
| Dec 31, 2023 | -14,000.00 |
| Sep 30, 2023 | -53,000.00 |
| Jun 30, 2023 | -225,000.00 |
| Mar 31, 2023 | 51,000.00 |
| Dec 31, 2022 | -38,000.00 |
| Sep 30, 2022 | -36,000.00 |
| Jun 30, 2022 | -37,000.00 |
| Mar 31, 2022 | -38,000.00 |
| Dec 31, 2021 | -95,000.00 |
| Sep 30, 2021 | 59,000.00 |
| Jun 30, 2021 | 19,000.00 |